Maravai LifeSciences Announces Q2 2025 Earnings Call and Webcast

Maravai LifeSciences will announce Q2 2025 financial results on August 11, 2025, and host a conference call at 2:00 p.m. PT/ 5:00 p.m. ET. The company is a global provider of life science reagents and services to researchers and biotech innovators.

Maravai LifeSciences (NASDAQ: MRVI), a leading provider of life science reagents and services, has scheduled its second quarter 2025 financial results announcement for Monday, August 11, 2025, after market close. The company will host a conference call and webcast at 2:00 p.m. PT/ 5:00 p.m. ET on the same day. Investors can join via phone by dialing (800) 267-6316 or (203) 518-9783 with Conference ID MARAVAI, or access the webcast through the "Investors" section of Maravai's website [1].

Maravai LifeSciences provides critical products to enable the development of drug therapies, diagnostics, and novel vaccines, as well as supporting research on human diseases. The company's services include nucleic acid synthesis and biologics safety testing, serving many of the world's leading biopharmaceutical, vaccine, diagnostics, and cell and gene therapy companies [1].

The financial results will provide insights into the company's performance during the second quarter of 2025, including revenue, earnings, and operational metrics. Investors and financial professionals are encouraged to participate in the conference call or webcast to gain a comprehensive understanding of Maravai's financial health and strategic direction.

References:
[1] https://www.stocktitan.net/news/MRVI/maravai-life-sciences-to-host-earnings-conference-call-on-monday-8glxr43hqay2.html